Remedium Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
19
Remedium Bio General Information
Description
Developer of gene therapies designed to come up with treatments for a broad range of diseases. The company's specialized gene therapy combines proven technologies in novel ways and their pipeline products include treatments in the fields of endocrinology, cardiology, and hematology, enabling patients to receive access to several therapeutic therapies for immune and age-related conditions.
Contact Information
Website
www.remedium-bio.comCorporate Office
- 15 Necco Street
- Floor 4
- Boston, MA 02210
- United States
Corporate Office
- 15 Necco Street
- Floor 4
- Boston, MA 02210
- United States
Remedium Bio Timeline
Remedium Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 10-Aug-2026 | $10M | Completed | Pre-Clinical Trials | ||
| 7. Later Stage VC | 23-Sep-2025 | Completed | Pre-Clinical Trials | |||
| 6. Debt - General | 28-Aug-2024 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 01-Jun-2024 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 15-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 16-Apr-2021 | $1.2M | $1.2M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 08-Oct-2020 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Remedium Bio Comparisons
Industry
Financing
Details
Remedium Bio Competitors (4)
One of Remedium Bio’s 4 competitors is Cytonics, a Venture Capital-Backed company based in Jupiter, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytonics | Venture Capital-Backed | Jupiter, FL | ||||
| Synartro | Venture Capital-Backed | Stockholm, Sweden | ||||
| Unity Biotechnology | Formerly VC-backed | South San Francisco, CA | ||||
| GQ Bio Therapeutics | Formerly VC-backed | Hamburg, Germany |
Remedium Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Remedium Bio Patents
Remedium Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026161611-A1 | Compositions and methods for optimizing expression of proteins in subcutaneous tissues | Pending | 22-Jan-2025 | ||
| WO-2026161611-A9 | Compositions and methods for optimizing expression of proteins in subcutaneous tissues | Pending | 22-Jan-2025 | ||
| WO-2026161566-A2 | Sequences for optimal processability of secreted therapeutic proteins delivered via vectors administered as a subcutaneous injection | Pending | 22-Jan-2025 | ||
| WO-2026161566-A3 | Sequences for optimal processability of secreted therapeutic proteins delivered via vectors administered as a subcutaneous injection | Pending | 22-Jan-2025 | ||
| WO-2026096751-A1 | Non-viral gene delivery system compositions | Pending | 30-Oct-2024 | A61K31/7105 |
Remedium Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Remedium Bio Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eli Lilly and Company Foundation | Limited Partner | Minority | ||
| Healthspan Capital | Venture Capital | Minority | ||
| HKX Capital | Venture Capital | Minority | ||
| Lilly USA | Corporation | Minority | ||
| Imbolc Partners | Venture Capital | Minority |
Remedium Bio FAQs
-
When was Remedium Bio founded?
Remedium Bio was founded in 2020.
-
Where is Remedium Bio headquartered?
Remedium Bio is headquartered in Boston, MA.
-
What is the size of Remedium Bio?
Remedium Bio has 19 total employees.
-
What industry is Remedium Bio in?
Remedium Bio’s primary industry is Drug Discovery.
-
Is Remedium Bio a private or public company?
Remedium Bio is a Private company.
-
What is Remedium Bio’s current revenue?
The current revenue for Remedium Bio is .
-
How much funding has Remedium Bio raised over time?
Remedium Bio has raised $21.3M.
-
Who are Remedium Bio’s investors?
Eli Lilly and Company Foundation, Healthspan Capital, HKX Capital, Lilly USA, and Imbolc Partners are 5 of 19 investors who have invested in Remedium Bio.
-
Who are Remedium Bio’s competitors?
Cytonics, Synartro, Unity Biotechnology, and GQ Bio Therapeutics are competitors of Remedium Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
